Interestingly, we demonstrated the ability of the peptide LDFI to reverse the leptin-mediated up-regulation of its own gene expression underlying how this peptide negatively interferes in the short autocrine loop maintained by leptin on Ob gene in breast cancer cells. Here, LEP is linked to breast cancer.